 |
Arcitumomab |
|---|---|
| Trade Name | 99m Tc-Labeled Cea-Scan |
| Orphan Indication | Diagnosis and localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1996-05-10 00:00:00 |
| Sponsor | Immunomedics, Inc.;300 American Road;Morris Plains, New Jersey, 07950 |
